In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
501 News Items found
Dr. Christopher Klebanoff
Feature
A New Type of Immunotherapy: MSK’s Christopher Klebanoff Is Fighting Cancer Cells From the Inside Out With T Cell Receptor (TCR) Therapy

Learn how MSK physician-scientist Christopher Klebanoff is working to bring immunotherapy to more patients, especially those with solid tumors.
Pouring white wine into a glass
Feature
White Wine and Melanoma: Does Drinking Alcohol Increase Your Cancer Risk?

Hear from our experts about a new study linking alcohol consumption and melanoma risk.
MSK patient Marc Scarduffa seen holding his dog at the beach.
Clinical Trials at MSK Aim To Reduce Side Effects of Cancer Treatment

Learn how MSK is Improving patients’ quality of life with less toxic treatments.
Overcoming Stomach Cancer and the CDH1 Mutation, Thanks to MSK
Overcoming Stomach Cancer and the CDH1 Mutation, Thanks to MSK

Meghan Winston chose Memorial Sloan Kettering Cancer Center to surgically remove her stomach—called a total gastrectomy—to protect against a deadly form of stomach cancer caused by a rare mutation in the CDH1 gene.
Three men standing in an airport
Feature
Exporting Expertise: How MSK Is Helping to Improve Cancer Care and Research in Ghana

Learn about a new initiative led by MSK pediatric hematologic oncologist Tanya Trippett that aims to improve cancer care and research in Ghana.
Dr. Yelena Janjigian hugs MSK patient Cecilia Defoe
New Gastric & Esophageal Cancer Treatment Breakthrough

There are new, FDA-authorized treatment options for people facing esophageal and gastric (stomach) cancer, thanks to clinical trials at Memorial Sloan Kettering that combined immunotherapy with standard treatments.
Memorial Sloan Kettering breast cancer expert Mark Robson.
Feature
Who Should Be Tested for a BRCA Mutation? The Science Is Evolving

Though questions remain about how best to use genetic testing for cancer, the trend is toward more inclusive criteria.
Graphic showing 11 cancer drugs approved by the FDA based on significant work done at MSK
MSK Research Led to FDA Approvals for Cancer Drugs in 2024

The U.S. Food and Drug Administration (FDA) approved 11 cancer drugs in 2024 based on significant contributions from MSK researchers.
Pictured: Breast tumor treated with paclitaxel
In the Lab
Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.
Group of Black men posing at prostate cancer fundraising walk.
Annual Prostate Cancer Screening Pays Off for Black Community Leader in Harlem

A Black community leader seeks prompt treatment for prostate cancer, avoiding the harsh toll the disease often takes on men like him.